Endovascular Treatment Devices Market to Reach USD 9.7 Billion by 2036, Driven by Rising Vascular Disease Burden and Minimally Invasive Technologies

The global endovascular treatment devices market was valued at US$ 3.7 billion in 2025 and is projected to reach US$ 9.7 billion by 2036, expanding at a CAGR of 9.2% from 2026 to 2036. The market is witnessing sustained growth as the prevalence of cardiovascular and peripheral vascular diseases continues to increase worldwide.

Endovascular treatment devices are medical instruments designed to diagnose and treat arterial and venous conditions through minimally invasive procedures. Using catheters, guidewires, imaging technologies, stents, grafts, and other specialized devices, physicians can access affected blood vessels through small incisions rather than conventional open surgery.

The growing adoption of angioplasty, stenting, thrombectomy, and endovascular aneurysm repair (EVAR) is contributing to market expansion. Minimally invasive interventions can offer shorter recovery periods and reduced procedural trauma compared with traditional surgical approaches.

Download to explore critical insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56028

Key Drivers of Market Growth

Rising Prevalence of Cardiovascular and Vascular Diseases

The increasing incidence of cardiovascular and vascular conditions, including peripheral artery disease (PAD), aneurysms, thrombosis, and other vascular disorders, is creating demand for endovascular treatment solutions. Aging populations, diabetes, hypertension, obesity, sedentary lifestyles, and dietary risk factors are contributing to the growing burden of vascular disease.

As healthcare providers increasingly adopt minimally invasive interventions, demand is rising for advanced stents, stent-grafts, balloon catheters, embolic protection systems, and thrombectomy devices. These technologies enable physicians to restore blood flow and treat vascular abnormalities while limiting surgical trauma.

Technological Advancements

Technological innovation is another major factor supporting market growth. Improvements in stent design, balloon catheters, grafts, guidewires, thrombectomy systems, and imaging-guided navigation are helping physicians perform increasingly complex vascular procedures.

Emerging technologies such as drug-eluting stents, bioresorbable materials, robotics-assisted interventions, and artificial intelligence-based procedural guidance are also expanding the capabilities of endovascular therapy. Improved delivery systems and imaging technologies are contributing to greater procedural precision and supporting wider adoption.

Key Players and Industry Leaders

The competitive landscape includes established medical-device manufacturers and specialized endovascular technology companies. Major participants include Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Cardinal Health, Endospan Ltd., Abbott Laboratories, Cook, W. L. Gore & Associates, Inc., Penumbra, Inc., Cordis Corporation, Endologix LLC, and Lombard Medical, among others.

Companies are focusing on product development, regulatory approvals, clinical studies, portfolio expansion, and strategic initiatives to address the growing demand for minimally invasive vascular treatments.

Access detailed insights by visiting our full report - https://www.transparencymarketresearch.com/endovascular-treatment-devices-market.html

Key Trends for the Future

The market is expected to be shaped by continued movement toward minimally invasive vascular care. Growing demand for procedures associated with shorter hospital stays and recovery periods is encouraging hospitals and ambulatory surgical centers to expand endovascular capabilities.

Another important trend is the development of next-generation EVAR systems, drug-eluting technologies, advanced thrombectomy devices, and precision-guided catheter systems. Increasing use of imaging technologies and digitally enabled procedural tools is also expected to improve the management of complex vascular conditions.

Investment Opportunities

Emerging economies represent an important opportunity for market participants as healthcare infrastructure develops and awareness of minimally invasive therapies increases. Expanding access to specialized vascular care, increasing healthcare expenditure, and the growing prevalence of chronic diseases can support demand for endovascular technologies.

However, investors and industry participants must also consider challenges including high device and procedure costs, differences in reimbursement, regulatory requirements, and shortages of highly trained interventional specialists in certain markets.

Future Outlook

Percutaneous Endovascular Aneurysm Repair (EVAR) devices accounted for the largest product segment, with a 28.7% market share in 2025. EVAR provides a minimally invasive approach for treating abdominal and thoracic aortic aneurysms using stent-grafts and endografts.

North America held the largest regional share in 2025, accounting for 38.7% of global revenue. The region benefits from established healthcare infrastructure, the presence of major medical-device manufacturers, availability of trained specialists, and adoption of advanced vascular procedures.

Over the 2026–2036 forecast period, growth is expected to remain supported by the aging population, increasing vascular disease burden, technological innovation, and expanding adoption of minimally invasive treatment approaches.

Buy this Premium Research Report to explore detailed market trends - https://www.transparencymarketresearch.com/checkout.php?rep_id=56028<ype=S

Market Segmentation

The endovascular treatment devices market can be segmented by product type, procedure type, application, end-user, and region.

By Product Type: Percutaneous EVAR devices, fenestrated EVAR devices, self-expanding nitinol stents, aortic stents, thoracic aortic aneurysm grafts, and others.

By Procedure Type: Balloon angioplasty, angioplasty with stent placement, drug-eluting stent procedures, thrombolysis/thrombectomy, renal artery angioplasty and stenting, and others.

By Application: Vascular, cardiology, neurology, and others.

By End-user: Hospitals, ambulatory surgical centers, and others.

By Region: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Important FAQs

What is the projected size of the endovascular treatment devices market by 2036?

The market is projected to reach approximately US$ 9.7 billion by 2036.

What is the expected market growth rate?

The market is forecast to expand at a 9.2% CAGR between 2026 and 2036.

Which region dominated the market in 2025?

North America dominated the global market with a 38.7% revenue share in 2025.

Which product segment held the largest share in 2025?

Percutaneous EVAR devices accounted for the largest share at 28.7%.

What are the major factors driving market growth?

Rising cardiovascular and vascular disease prevalence, an aging population, growing adoption of minimally invasive procedures, and technological advancements in endovascular devices are key growth factors.

Who are the major market participants?

Key companies include Medtronic, Boston Scientific, Terumo, Cardinal Health, Endospan, Abbott Laboratories, Cook, W. L. Gore & Associates, Penumbra, Cordis, and Endologix, among others.

Explore Latest Research Reports by Transparency Market Research-

Mammography Systems Market

Robotic Surgical Microscopy Market

Influenza Diagnostics Market

Interbody Fusion Cages Market

ELISA Analyzers Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com